Journey Medical Corp (DERM) Free cash flow 2023–2025
Journey Medical Corp (DERM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$27.4MFY2025 · since FY2023: -$14.8M → -$27.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$27.4M | -94.2% |
| FY2024 | -$14.1M | +4.3% |
| FY2023 | -$14.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More DERM financial trends
DERM RevenueDERM Net incomeDERM Net marginDERM Gross profitDERM Gross marginDERM Operating incomeDERM Operating marginDERM Operating cash flowDERM Capital expendituresDERM Return on equityDERM Stock buybacksDERM Dividends paidDERM Total assetsDERM Total liabilitiesDERM Shareholders’ equityDERM overview →